Category Archives: Momentum & Growth

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) plunged into the close of 2016, and hasn’t been able to stage any degree of recovery throughout early 2017. The company fell foul of some negative data surrounding its lead asset in December,...

InterCloud Systems Inc (OTCMKTS:ICLD) is still struggling. We looked at the company on a couple of occasions during the latter half of 2016, suggesting that – fundamentally at least – there should be some long-term growth potential to its...

Bemax Inc (OTCMKTS:BMXC) has had a great start to 2017. The company closed out last year trading for just $0.006 a share. Fast forward to the end of last week, and this had risen to $0.017 a share. It’s still a microcap, but the close...

Opexa Therapeutics Inc (NASDAQ:OPXA) ran up towards the end of last week on a spike in volume, despite a lack of any clear catalysts. The company has been something of a dead entity for the last couple of months, having put out data from its...

Proto Script Pharmaceutical Corp (OTCMKTS:PSCR) has risen from $0.32 a share at the start of December to $1.62 a share at last close, a more than 400% gain across the period.  There is a promotional campaign running in the background right...

It has been a big week for low float runners in the biotech space, and things don’t look like they’re going to slow down as the week draws to a close. Another example of this sort of action has just popped up, in the form of MYOS...

We’re always on the lookout for biotech runners, and one that’s impossible to overlook right now is Transgenomic Inc (NASDAQ:TBIO). The company gained close to 300% on Thursday, and looks set to continue its run into the end of...

  A position taken in World Media & Technology Corp (OTCMKTS:WRMT) last summer would have proven to be one of the best technology exposures available over the subsequent six to seven months. On August 28, 2016, World Media traded for...

Dextera Surgical Inc (NASDAQ:DXTR) is up more than 120% so far this week, on a corporate update put out by management to address the fiscal 2017 sales of its lead asset. If the numbers outlined in the update can be hit, and based on the numbers...

When Rennova Health Inc (NASDAQ:RNVA) announced mid December that it was pricing a public offering, the company took a considerable hit. Throughout the latter half of the month, and into early 2017, this decline continued. Late this week, however,...

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter